Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

NCT03566316 PHASE3 COMPLETED

A Randomized, Double-blind, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine and Rosuvastatin Co-administration in Hypertensive Patients with Hyperlipidemia

Details

Lead sponsor	IlDong Pharmaceutical Co Ltd
Phase	PHASE3
Status	COMPLETED
Enrolment	134
Start date	Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jun 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Hypertension With Hyperlipidemia

Interventions

• Telmisartan/Amlodipine
• Rosuvastatin
• Telmisartan

Countries

South Korea